Slocum, Gordon & CO LLP has filed its 13F form on January 28, 2025 for Q4 2024 where it was disclosed a total value porftolio of $115 Million distributed in 137 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $9.73M, Procter & Gamble CO with a value of $8.71M, Exxon Mobil Corp with a value of $8.12M, Johnson & Johnson with a value of $6.85M, and Abb Vie Inc. with a value of $6.81M.

Examining the 13F form we can see an decrease of $397M in the current position value, from $512M to 115M.

Slocum, Gordon & CO LLP is based out at Newport, RI

Below you can find more details about Slocum, Gordon & CO LLP portfolio as well as his latest detailed transactions.

Portfolio value $115 Million
Healthcare: $28.5 Million
Consumer Defensive: $18.3 Million
Energy: $16 Million
Utilities: $15.6 Million
Communication Services: $7.89 Million
Industrials: $6.61 Million
Technology: $5.88 Million
Financial Services: $5.72 Million
Other: $10.1 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 137
  • Current Value $115 Million
  • Prior Value $512 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 28, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.